United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $3.63 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,463 shares of the company’s stock after purchasing an additional 9,166 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in GE HealthCare Technologies were worth $3,632,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. Graney & King LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at about $75,000. Trust Investment Advisors raised its holdings in GE HealthCare Technologies by 55.5% in the 4th quarter. Trust Investment Advisors now owns 8,350 shares of the company’s stock valued at $653,000 after acquiring an additional 2,979 shares in the last quarter. TIAA Trust National Association lifted its position in shares of GE HealthCare Technologies by 2.8% in the 4th quarter. TIAA Trust National Association now owns 10,604 shares of the company’s stock worth $829,000 after acquiring an additional 291 shares during the period. Modern Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $187,000. Finally, EntryPoint Capital LLC bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $357,000. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $82.46 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $37.71 billion, a price-to-earnings ratio of 19.04, a PEG ratio of 3.19 and a beta of 1.13. The firm’s 50 day moving average is $86.91 and its 200-day moving average is $85.96. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.